4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0001104659-24-132160
Chief Legal Officer sold 4,519 shares at $7.43 ($33,576)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Sullivan Mark · Chief Legal Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-12-26 | Sale : show line 1 in the form 10b5-1 | −4,519 | $7.43 | $33,576 | 173,197 | D |
| Open-market sales · 4,519 sh · avg $7.43 · $33,576 | ||||||
Loading xslF345X05/tm2432133-1_4seq1.xml…